Why the study?
Does measuring creatine kinase MB isoenzyme improve the diagnosis of myocardial infarction in patients with total creatine kinase > 1000 U/L?
Does measuring creatine kinase MB isoenzyme improve the diagnosis of myocardial infarction in patients with total creatine kinase > 1000 U/L?
Answers are grounded in this paper and cite their sources.
In patients with markedly elevated total creatine kinase (>1000 U/L), a creatine kinase MB fraction >2% is the most appropriate cutoff for diagnosing myocardial infarction to balance false positives and missed cases.
The usefulness of measuring creatine kinase MB isoenzyme for diagnosing myocardial infarction when activities of total creatine kinase are very high is unclear. We conducted a retrospective study in an urban hospital that serves a largely indigent population. We concentrated on 146 patients whose creatine kinase activity was greater than 1000 U/L (upper limit of normal: 165 U/L for women and 225 U/L for men), with MB isoenzyme greater than 10 U/L and less than 5% of total creatine kinase. The positive predictive value of MB isoenzyme (isoimmune method) values greater than 10 U/L was between 11.6% and 56.8% when the value for total creatine kinase exceeded 1000 U/L. Using different values (MB greater than 4% of total creatine kinase) as positive for myocardial infarction would have resulted in far fewer false-positives, but 10 cases of myocardial infarction would have been missed. The most appropriate cutoff value for MB isoenzyme in this population (total creatine kinase greater than 1000 U/L) was found to be greater than 2% of total creatine kinase.
No takes yet. Share an insight, caveat, or question.
Thompson et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: